Work

A single-arm feasibility trial of memantine to prevent chemotherapy-related cognitive decline in patients with early breast cancer.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.12109

Authors: Zev Nakamura, Allison Mary Deal, Eliza Myung Park, Kate Stanton, Yesy Lopez, Laura J. Quillen, Erin O'Hare Kelly, Hillary M Heiling, Kirsten A. Nyrop, Emily Miller Ray, Elizabeth Claire Dees, Katherine Elizabeth Reeder-Hayes, Trevor Augustus Jolly, Lisa A. Carey, Yara Abdou, Oludamilola A. Olajide, Megan Ann McNamara, Tim Ahles, Hyman B. Muss

Institutions: University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Duke Medical Center, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Cancer-related cognitive impairment studies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

OpenAlex ID: W4286294880

Cites:

Cited by:

Related to: 10